Globe Registry: Globe® Pulsed Field System Registry Study for Treating Patients With Symptomatic Atrial Fibrillation

Kardium Inc.

Summary

This post-market registry is designed to collect real world data on the use of the Globe PF System for the treatment of atrial fibrillation (AF).

Eligibility

Age range: 18+ years
Sex: All
Healthy volunteers: No

Detailed criteria

Key Inclusion Criteria: * Patients with a planned ablation procedure using the commercially available Globe PF System Key Exclusion Criteria: * Patients whose life expectancy is 1 year or less * Contraindication to left atrial catheter ablation or PF ablation * Current enrollment in any investigational study of a medical device, biologic, or drug not pre-approved by Kardium

Interventions

Device
Globe Pulsed Field System
Ablation and atrial mapping with the Globe Pulsed Field System

Locations (2)

Arrhythmia Research Group
Jonesboro, Arkansas
Overlake Hospital
Bellevue, Washington

Globe Registry: Globe® Pulsed Field System Registry Study for Treating Patients With Symptomatic Atrial Fibrillation

Summary

Eligibility

Interventions

Locations (2)

Run this study?

Details

Conditions